Arizona Patent of the Month – June 2022
Medical imaging is an important technology. Advancements have made it possible to produce reliable images through X-rays, CT scans, ultrasounds and more. The precision of the imagery is crucial for doctors to make correct diagnoses and decisions for treatment. For instance, a cancer diagnosis is often achieved by surgically removing suspicious tissue in a biopsy. This tissue is then further examined by a radiologist or pathologist who will use imaging technology to identify appropriate tissue margins. These margins inform the surgeon of exactly how much tissue needs to be excised. If the margins are off, cancerous tissue may remain.
Faxitron Bioptics, LLC has designed an imaging system with adaptive object magnification, capable of providing both 2 and 3-D imaging. The adaptive magnification makes it possible to complete tissue margin verification with a degree of confidence. It can also allow this process to be completed in the surgery room, meaning each case can be completed more rapidly. In this way, a patient can have the biopsy and excision in one go, rather than undergoing multiple procedures while the bioptic tissue is sent for examination.
The device is automated and removes the need for manual repositioning of the specimen or the electromagnetic radiation source during imaging. The images are displayed on a screen, and the variable control of magnification allows the doctor to slice through the 3D image at nearly any position, revealing the internal details. Adjustment of the magnification ensures the image will be captured at the desired depth. Since it can be modified in real time, the doctor can get a detailed view of the specimen without needing to order new images.
Faxitron, part of Hologic Inc., is dedicated to the science and technology of non-destructive testing. These solutions allow scientists and researchers a better chance at more timely discoveries and advancements in the industries of pre-clinical, agriculture, and forensic imaging and non-destructive testing.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.